Effectiveness of Different Methods in Acute Myofascial Pain Syndrome

Sponsor
Ufuk University (Other)
Overall Status
Completed
CT.gov ID
NCT04827303
Collaborator
(none)
75
1
24
3.1

Study Details

Study Description

Brief Summary

This study is a randomized controlled study. A total of 75 patients between the ages of 20-50 who have a diagnosis of acute myofacial pain syndrome in the trapezius muscle and have pain for a maximum of 5 days were included in the study. Patients were randomly divided into 3 groups. Group 1 patients received kinesio tape method (25 patients), group 2 patients received trigger point injection method (25 patients), and group 3 patients received neural therapy injection method (25 patients). A 10-15 cm sized I band was applied to the trapezius muscles of the first group patients with the patient's neck in lateral flexion. Then, while the patient's neck is flexed, a Y-shaped 15-20 cm tape will be affixed between C1-7 with the arms of the Y up, and I tape of 5-10 cm is attached on the arms. In group 2 patients, 1 cc lidocaine diluted with 4 cc saline (SF) was applied to the trigger points palpated manually in the trapezius muscles. After the trigger point was squeezed between the thumb and index finger, a few cc of local anesthetic mixture was applied into the trigger point with the injector and exited. In the 3rd group patients, a few cc local anesthetic mixture will be applied intradermally over the trigger point without entering into the trigger points palpated manually in the trapezius muscles. Patients were checked 72 hours and 1 week after the first applications.

The pain at rest and during movement of the patients in all 3 groups were evaluated with a visual analog scale (VAS 10 cm). The number of trigger points was determined by the physician by hand palpation. Pressure pain threshold was evaluated with the algometer device. Disability assessment of the patients was made using the neck pain disability index. evaluations were made at the beginning of treatment, 72 hours after and 1 week after treatment.

Condition or Disease Intervention/Treatment Phase
  • Other: Kinesio taping

Study Design

Study Type:
Observational
Actual Enrollment :
75 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Effectiveness of 3 Different Methods in Acute Myofascial Pain Syndrome: A Randomized Controlled Study
Actual Study Start Date :
Apr 1, 2017
Actual Primary Completion Date :
Apr 1, 2019
Actual Study Completion Date :
Apr 1, 2019

Outcome Measures

Primary Outcome Measures

  1. Visual analog scale [1 week]

    The pain at rest and during movement of the patients in all 3 groups were evaluated with a visual analog scale (VAS 10 cm).

  2. The number of trigger points [1 week]

    The number of trigger points was determined by the physician by hand palpation.

  3. Pressure pain threshold [1 week]

    Pressure pain threshold was evaluated with the algometer device.

  4. Neck pain disability index [1 week]

    Disability assessment of the patients was made using the neck pain disability index.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients diagnosed with acute myofascial pain syndrome

  • Patients between the ages of 20-50

  • Patients with pain for up to 5 days

Exclusion Criteria:
  • Patients diagnosed with fibromyalgia

  • Patients with systemic disease

  • Patients with prominent cervical disc herniation

  • Patients with cervical arthrosis

  • Patients with cervical radiculopathy and myelopathy

  • Patients with myofascial trigger point injection in the past 6 months

  • Patients who received physical therapy in the past 6 months

  • Patients undergoing shoulder and neck surgery

  • Patients with drug allergies

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ufuk University Ankara Turkey

Sponsors and Collaborators

  • Ufuk University

Investigators

  • Principal Investigator: saime ay, Ufuk University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Saime Ay, Professor Doctor, Ufuk University
ClinicalTrials.gov Identifier:
NCT04827303
Other Study ID Numbers:
  • 29032017-8
First Posted:
Apr 1, 2021
Last Update Posted:
Apr 1, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 1, 2021